Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: enalapril attending: chief complaint: for foot surgery major surgical or invasive procedure: foot surgery history of present illness: 57 yo m s/p podiatry surgery transferred from the pacu with hypotension, hyperglycemia, hyperkalemia. he has a history of l foot i&d for abscess and wound cultures in with mrsa treated with vancomycin beads. intraop course without complications with 700cc blood loss. in the pacu, hct 24.6, low urinary output 30cc, k 5.5. sbp 90s. a-line placed. anesthesia contact for transfer based on hypotension with low u/o, low hct, hyperkalemia. gave 4.7l fluid. 2uprb plus lasix . he denied cp, sob, leg pain. no n/v. he denies sob with exersion, orthopnea, pnd. bp stablised and transferred to the floor. past medical history: charcots foot: : s/p tibio-calcaneal athrodesis with femoral head graft and intramedullary nail. external fixation stabilization. mrsa wound culture dm2 x20 years htn asthma gerd hypercholesterolemia bronchitis obesity cad s/p cardiac stent lad , denies cp, hypothyroidism s/p charcot recon . h/o abscess of left foot s/p i&d s/p appendecomy s/p tonsillectomy social history: hx of tobacco abuse, 72 pack-yr hx, quit 5 yrs ago; hx of alcohol abuse; no ivda lives alone, manages his own medications quit smoking in reports occasional etoh use family history: father- deceased from stroke-66 yo mother-deceased, diabetic mellitus complications physical exam: in icu: vs: t98.1 83 102/48 sat 100%2lnc gen: awake and alert, nad cv: distant heart sounds, rrr, nl s1, s2, no m/r/g, jvp 7cm resp: ctab abd: obese, nontender, nondistended, bs present. ext: cool, no cyanosis or edema. cast on lle. diminished pedal pulses. neuro: awake and alert. able to move lower extremities. decreased sensation l and r le. pertinent results: 07:32pm glucose-169* urea n-42* creat-1.8* sodium-139 potassium-5.5* chloride-112* total co2-18* anion gap-15 07:32pm calcium-7.9* phosphate-5.5*# magnesium-1.7 07:32pm wbc-11.2* rbc-2.93*# hgb-8.3* hct-24.6* mcv-84 mch-28.2 mchc-33.6 rdw-16.9* 07:32pm plt count-283 03:05pm glucose-192* . blood cx : pending blood cx : coag neg staph left foot antibiotic bead cx : no growth . ekg: sinus rhythm first degree av block lateral st-t changes are nonspecific since previous tracing, no significant change . foot path: left foot bone, debridement (a): bone with chronic inflammation, focal giant cell reaction, intramedullary granulation tissue, and reactive changes. no acute osteomyelitis is present. . foot and lower leg, five views findings: comparison . an external fixator device has been placed around the lower leg and foot. evaluation of the osseous structures is severely limited due to the overlying hardware. extensive post-operative changes of the hindfoot are seen. a bone stimulation device is also noted. lucent tracts in the osseous structures reflect previous hardware. evidence of previous distal fibular resection is seen. impression: interval placement of external fixator device. extensive post-operative changes of the lower leg and hindfoot. evaluation is obscured by the overlying device. . angio for picc placement: impression: successful placement of a 42 cm long single lumen line placed via the left brachial vein with tip in the distal svc. the line is ready for use. brief hospital course: # hypotension: resolved with ivf and 2 units prbc. suspect due to hypovolemia + anesthesia/fluid shifts but continued on antibiotics in house for risk of component of presepsis. lopressor initially held but has been restarted and patient is tolerating this, in addition to his regular blood pressure medications. . # chronic osteomyelitis s/p left rear foot arthrodesis: patient tolerated the surgery well. his antibiotic bead was removed during the surgery. he was continued on vancomycin, levofloxacin, and flagyl per podiatry in house and will continue outpatient on iv vancomycin only with follow-up with dr. for continued management. per podiatry, anticipate 4-6 weeks iv antibiotics. immobilizer in place. dressing change to be done by dr. in follow-up on . . # chronic renal insufficiency: patient remained at his baseline cr 1.3-1.5. lytes stable. euvolemic. . # type 2 diabetes: hgb a1c elevated (8.8% in ). patient continued on his home lantus 70 units qday, regular insulin 30 units qam and 30 u qpm, and pioglitazone 45mg po qday. . # history of alcohol abuse: patient was monitored on ciwa but required no benzo. . ## ppx: hep sc, ppi, venodynes . # access: picc placed by angio prior to discharge for continued iv antibiotics picc line. . # code: full . # communication: no family or friends that he would want to take part in his medical decision making. medications on admission: levothyroxine 300mcg po qday ascorbic acid 500mg po bid lopressor 75mg po bid asa 81mg po qday lipitor 20mg po qday nortriptyline 75mg po qday oxycodone prn ca carbonate 500mg po tid protonix 40mg po qday pioglitazone 45mg po qday epoetin 8000 qmowefr, kcl 20 meq po bid ferrous gluconate 300mg po tid fexofenadine 60mg po qday finasteride 5mg po qday fluticasone-salmeterol (250/50) ih tamsulosin 0.4mg po qday tiotropium bromide 1 cap ih qday hydralazine 40 q6h riss lantus 40 units qday isosorbide mononitrate (er) 60mg qday discharge medications: 1. acetaminophen 325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed. 2. heparin (porcine) 5,000 unit/ml solution sig: one (1) injection tid (3 times a day). 3. ascorbic acid 500 mg tablet sig: one (1) tablet po bid (2 times a day). 4. levothyroxine 100 mcg tablet sig: three (3) tablet po daily (daily). 5. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). 6. nortriptyline 25 mg capsule sig: three (3) capsule po daily (daily). 7. atorvastatin 20 mg tablet sig: one (1) tablet po daily (daily). 8. calcium carbonate 500 mg tablet, chewable sig: one (1) tablet, chewable po tid (3 times a day) as needed. 9. epoetin alfa 3,000 unit/ml solution sig: one (1) injection qmowefr (monday -wednesday-friday). 10. ferrous gluconate 300 mg tablet sig: one (1) tablet po tid (3 times a day). 11. fexofenadine 60 mg tablet sig: one (1) tablet po daily (daily). 12. finasteride 5 mg tablet sig: one (1) tablet po daily (daily). 13. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 14. tamsulosin 0.4 mg capsule, sust. release 24hr sig: one (1) capsule, sust. release 24hr po hs (at bedtime). 15. tiotropium bromide 18 mcg capsule, w/inhalation device sig: one (1) cap inhalation daily (daily). 16. metoprolol tartrate 50 mg tablet sig: one (1) tablet po bid (2 times a day). 17. pioglitazone 15 mg tablet sig: three (3) tablet po qam (once a day (in the morning)). 18. isosorbide mononitrate 30 mg tablet sustained release 24hr sig: two (2) tablet sustained release 24hr po daily (daily). 19. polyethylene glycol 3350 17 g (100%) packet sig: one (1) packet po qd (). 20. docusate sodium 100 mg capsule sig: one (1) capsule po tid (3 times a day). 21. magnesium hydroxide 400 mg/5 ml suspension sig: thirty (30) ml po q6h (every 6 hours) as needed for abdominal discomfort. 22. hydralazine 10 mg tablet sig: four (4) tablet po q6h (every 6 hours). 23. omeprazole 20 mg capsule, delayed release(e.c.) sig: two (2) capsule, delayed release(e.c.) po qd (). 24. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. 25. morphine 15 mg tablet sig: one (1) tablet po q4-6h (every 4 to 6 hours) as needed. 26. heparin flush picc (100 units/ml) 2 ml iv daily:prn 10 ml ns followed by 2 ml of 100 units/ml heparin (200 units heparin) each lumen daily and prn. inspect site every shift. 27. lantus 100 unit/ml cartridge sig: seventy (70) units subcutaneous at bedtime. 28. insulin regular human 100 unit/ml cartridge sig: thirty (30) units injection qam and qdinner. 29. insulin lispro (human) 100 unit/ml cartridge sig: one (1) injection subcutaneous three times a day: per sliding scale. 30. vancomycin in dextrose 1 g/200 ml piggyback sig: one (1) gram intravenous q 12h (every 12 hours): anticipate 4-6 weeks. disp:*60 gram* refills:*2* discharge disposition: extended care facility: rehabilitation & nursing center - discharge diagnosis: primary: s/p left rear foot arthrodesis hypotension diabetes mellitus secondary: hypertension asthma gerd hypercholesterolemia cad s/p stent ' charcot foot with history of mrsa infection discharge condition: good: afebrile, pain well controlled discharge instructions: please monitor for temperature > 101, worsening pain or bleeding in the left foot, low or high blood sugars, chest pain, diarrhea, or other concerning symptoms. you will require to comple the course of iv antibiotics as indicated. followup instructions: please follow-up with dr. from podiatry on at 1:40 pm. phone: . location: () 3. please call to schedule follow-up with your primary care doctor within 1-2 weeks. talk to your primary doctor about getting a colonoscopy and upper endoscopy for work-up of your anemia. procedure: venous catheterization, not elsewhere classified transfusion of packed cells tarsometatarsal fusion diagnoses: coronary atherosclerosis of native coronary artery esophageal reflux congestive heart failure, unspecified asthma, unspecified type, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia, unspecified hypovolemia other bone involvement in diseases classified elsewhere chronic osteomyelitis, ankle and foot arthropathy associated with neurological disorders 

Answer: The patient is high likely exposed to